Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Nitto Denko Avecia

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

Looking for 1492984-65-2 / Inotersen API manufacturers, exporters & distributors?

Inotersen manufacturers, exporters & distributors 1

47

PharmaCompass offers a list of Inotersen API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Inotersen manufacturer or Inotersen supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Inotersen manufacturer or Inotersen supplier.

PharmaCompass also assists you with knowing the Inotersen API Price utilized in the formulation of products. Inotersen API Price is not always fixed or binding as the Inotersen Price is obtained through a variety of data sources. The Inotersen Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Inotersen

Synonyms

Tegsedi, Inotersen [usan], Unii-0ieo0f56lv, 0ieo0f56lv, Isis 420915, 1492984-65-2

Cas Number

1492984-65-2

About Inotersen

Inotersen is an antisense oligonucleotide (ASO) targeting transthyretin (TTR), which has potential use in the treatment of TTR amyloidosis (ATTR). Upon subcutaneous administration, inotersen targets and binds to messenger RNA (mRNA) for both variant and wild-type forms of TTR inside liver cells, thereby inhibiting translation of both mutant and wild-type TTR. Inhibition of TTR protein synthesis lowers TTR blood levels and decreases the amount of and/or prevents TTR amyloid deposits, which accumulate in and cause damage to various body organs and tissues. ATTR is caused by mutations in the TTR gene, which lead to TTR protein misfolding; misfolded wild-type and mutant forms of TTR protein accumulate in tissues as amyloid deposits in most ATTR patients.

Inotersen Manufacturers

A Inotersen manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Inotersen, including repackagers and relabelers. The FDA regulates Inotersen manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Inotersen API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

Inotersen Suppliers

A Inotersen supplier is an individual or a company that provides Inotersen active pharmaceutical ingredient (API) or Inotersen finished formulations upon request. The Inotersen suppliers may include Inotersen API manufacturers, exporters, distributors and traders.

Inotersen NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Inotersen as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Inotersen API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Inotersen as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Inotersen and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Inotersen NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Inotersen suppliers with NDC on PharmaCompass.

Inotersen Manufacturers | Traders | Suppliers

Inotersen Manufacturers, Traders, Suppliers 1
79

We have 1 companies offering Inotersen

Get in contact with the supplier of your choice:

  1. Nitto Denko Avecia
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.